The global Pharmacovigilance (PV) market size was USD 6.97 Billion in 2021 and is expected to register a revenue CAGR of 10.5% during the forecast period, according to latest analysis by Emergen Research. Increasing outsourcing of pharmacovigilance is a major factor driving market revenue growth. Small-scale biotech and pharmaceutical companies have a few internal resources with expertise in safety. Modern PV applications make it simple for businesses to outsource safety services without sacrificing control or data visibility. In addition, cloud technologies drive greater collaboration and transparency for improved coordination and communication between pharmaceutical companies and service providers or Clinical Research Organizations (CROs).
The latest report is furnished with a detailed examination of the Pharmacovigilance market and the global economic landscape ravaged by the ongoing COVID-19 pandemic. The pandemic has significantly affected millions of people’s lives. Besides, it has turned the global economy upside down, which has adversely impacted the Pharmacovigilance business sphere. Thus, the report encompasses the severe effects of the coronavirus pandemic on the Pharmacovigilance market and its key segments.
To get a sample copy of the global Graphene market report, visit @ https://www.emergenresearch.com/request-sample/81
Pharmacovigilance Market Competitive Terrain:
The global Pharmacovigilance market is highly consolidated due to the presence of numerous companies operating across this industry. The report depicts the current market standing of these companies, their past performances, demand and supply graphs, production and consumption patterns, sales network, distribution channels, and growth opportunities in the market. The leading market contenders listed in the report are: ArisGlobal, Accenture, Cognizant, Capgemini, IBM Corporation, IQVIA, BoClinica Inc., Laboratory Corporation of America Holdings, Linical Accelovance, and ITClinical, among others.
Pharmacovigilance Market Segmentation:
Emergen Research has segmented the global pharmacovigilance on the basis of type, service provider, clinical trial phase, end-users, and region:
Type Outlook (Revenue, USD Million; 2017-2027)
Intensified Adverse Drug Reaction (ADR) Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
Electronic Health Record (HER) Mining
Service Provider Outlook (Revenue, USD Million; 2017-2027)
Clinical Trial Phase Outlook (Revenue, USD Million; 2017-2027)
End-Users Outlook (Revenue, USD Million; 2017-2027)
To get the report at an incredible discount, visit @ https://www.emergenresearch.com/request-discount/81
Pharmacovigilance Market Key Highlights
In December 2019, UCB and Accenture made an announcement about signing of a partnership agreement to build a safety solution on INTIENT™ pharmacovigilance, by Accenture, to accelerate patient safety case reports’ processing. The agreement is intended to help UCB in discovering the influence of existing treatments on patient’s safety and therefore managing the novel drugs’ risk in a better way.
Spontaneous reporting is a crucial type in pharmacovigilance by providing information from real clinical settings in the course of a drug’s life. Physicians and many other healthcare specialists contribute immensely to improving public health by supposed adverse drug reactions’ reporting.
Several firms support in-house reporting management to healthcare authorities, as in-house reporting is possibly the major contact entity for any kind of in and out deliberation.
The escalating sophistication of biologics & therapeutic agents and the growing deployment of novel agents makes it essential to identify any undesired and unforeseen adverse events and other toxicities as early as possible. Popular instances associated with the withdrawal of a drug from the market after receiving sanction, verify Phase IV pharmacovigilance requirement.
Major Geographies Analyzed in the Report:
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia-Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
In conclusion, the report provides a qualitative and quantitative analysis of the Global Pharmacovigilance market, including the global and regional analysis of the market. The study covers critical information and factual data about the Pharmacovigilance market industry, along with an in-depth statistical analysis of the market drivers, limitations, growth prospects, opportunities, and threats. On the basis of the current market scope, the report provides an extensive analysis of how the Pharmacovigilance market is expected to fare in the forecast timeline. The report utilizes Pharmacovigilance analytical tools to offer an estimation of the outlook of the global state of the Pharmacovigilance market industry.
Request a customized copy of report @ https://www.emergenresearch.com/request-for-customization/81
Thank you for reading our report. For further details or to inquire about the customization of the report, please reach out to our team. We will offer you the report as per your requirements.
Take a Look at our Related Reports:
Masterbatch Market https://www.digitaljournal.com/pr/masterbatch-market-size-is-expected-to-reach-usd-16-31-billion-in-2028-and-register-a-revenue-cagr-of-4-8-by-2021-2028-latest-analysis-by-emergen-research
Cancer Immunotherapy Market https://www.digitaljournal.com/pr/cancer-immunotherapy-market-to-hit-153-03-billion-by-2027-emergen-research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
Visit for More Insights: https://www.emergenresearch.com/insights
Read Press Release@ https://www.emergenresearch.com/press-release/global-pharmacovigilance-market